Even as the Trump administration works to implement its “most favored nation” pricing system, the U.S. government continues to advance efforts to negotiate Medicare drug prices as enabled by the Inflation Reduction Act.
Related Posts
CMS finalizes rule cracking down on Medicaid provider taxes
Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: The CMS on Thursday finalized […]
The Risk of Trump’s Marijuana Order
For more than 50 years, America’s official position on marijuana has been seen as nonsensical. By classifying pot as a Schedule I drug, the federal […]
Monkeypox: Symptoms, Causes, Diagnosis & Treatment
WHO has declared monkeypox or Mpox a global emergency and pandemic, given the recent outbreak in multiple countries across the world. The Mpox virus is […]